Neomorph appoints Bell Zhong as Chief Financial Officer
Neomorph, Inc., a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets,’ recently announced the appointment of Bell Zhong as the company’s Chief Financial Officer. Mr. Zhong brings to Neomorph more than 17 years of investment banking and corporate finance leadership experience […]
